Explore more publications!

Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on October 29, 2025

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
Climb Global Solutions Reports Third Quarter 2025 Results
BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates
Veru Announces Proposed Public Offering
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
Aware Reports Third Quarter and Nine-Month 2025 Financial Results
NewHydrogen and Nuclear Power — A Perfect Pairing
Innovate NY Announces $4.2 Billion Annual Economic Output for New York City From Immigration Innovation Using Blockchain and Artificial Intelligence; Backs Andrew Cuomo for Mayor
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
Nature’s Miracle Menyerahkan Lisensi Royalti Sebesar 35% dan Lisensi Teknologi Global Senilai Jutaan Dolar kepada Datavault AI
Nature’s Miracle Anugerahkan Lesen Royalti 35% kepada Datavault AI Bersama Lesen Teknologi Global Bernilai Jutaan Dolar
ネイチャーズ・ミラクル (Nature’s Miracle)、数百万ドル規模のグローバル技術ライセンス契約に基づき、データボルトAI (Datavault AI) から35%のロイヤルティでライセンス取得
Nature’s Miracle, Datavault AI와 35% 로열티 부여하는 수백만 달러 규모 글로벌 기술 라이선스 체결
Nature's Miracle ประกาศมอบสัญญาอนุญาตให้ใช้สิทธิ์แบบมีค่าลิขสิทธิ์ 35% ให้แก่ Datavault AI…
Nature’s Miracle 授予 Datavault AI 35% 特许权使用费许可并签订价值数百万美元的全球技术许可协议
Nature’s Miracle 授予 Datavault AI 35% 專利權費許可,締結價值數百萬美元的全球技術授權
At the Peak of the x402 Boom: Gold Rush or Hidden Risk?
Chairman and CEO Stockholder Letter: Wrap Is Bringing Non-Lethal Back To Public Safety
Datavault AI Mengakuisisi API Media dalam Transaksi Tunai Penuh
Datavault AI, API Media를 전액 현금으로 인수

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions